KromaTiD

Longmont, CO · Founded 2007 · Privately Held (backing)

Developer of next-gen cytogenetic products focused on discovering, detecting, and diagnosing genomic rearrangements in the areas of oncology and rare diseases. KromaTiD is based in Longmont, CO and was founded in 2007. It was valued at $39 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $23.6 million across 5 recorded rounds; the latest was a $3.6 million seed round in Jul 2025.

PMV mark · valuation
$39.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$23.6M
Last round
Seed Round
Jul 2025
What is KromaTiD worth?
$39.0MPrivateMarketView mark · Oct 2026

Valued at $39.0M at its later-stage round, Jul 2025. Nothing has traded since.

Free account
More of KromaTiD with a free account
  • ·The complete investor list: 11 names
  • ·Watch KromaTiD: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

KromaTiD funding history

5 rounds
DateRoundRaisedPost-money
Jul 2025Seed Round$3.6M▮
Jan 2024Seed Round$2.1M▮
Sep 2021Early Stage VC$7.9M▮
Feb 2019Seed Round$1.9M▮
Dec 2016Seed Round$623K▮
Unlock post-money valuations

Membership and data by Private Market View

KromaTiD valuation

KromaTiD was valued at $39 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has KromaTiD raised?

KromaTiD has raised $23.6 million across 5 recorded rounds since 2016. The largest was a $7.9 million early-stage round in Sep 2021; the most recent was a $3.6 million seed round in Jul 2025.

KromaTiD has filed 8 Form Ds with the SEC since 2013, most recently in Jul 2025 ($3.6 million sold to 57 investors).

How KromaTiD's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For KromaTiD, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about KromaTiD

What is KromaTiD worth?
KromaTiD is valued at $39.0M as of Oct 2026. Valued at $39.0M at its later-stage round, Jul 2025. Nothing has traded since.
How much has KromaTiD raised?
KromaTiD has raised $23.6M in total funding across 5 recorded rounds.
When did KromaTiD last raise?
KromaTiD last raised in Jul 2025 (Seed Round), raising $3.6M.